$340 Million is the total value of Ghost Tree Capital, LLC's 46 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 81.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMMU | Sell | IMMUNOMEDICS INC | $29,588,000 | +9.5% | 1,250,000 | -32.4% | 8.71% | +59.3% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $24,650,000 | +205.9% | 500,000 | +90.5% | 7.25% | +345.0% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $23,132,000 | +32.9% | 175,000 | -25.5% | 6.81% | +93.3% |
| PTCT | Buy | PTC THERAPEUTICS INC | $22,768,000 | +320.7% | 675,000 | +237.5% | 6.70% | +512.0% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $20,683,000 | – | 210,000 | +100.0% | 6.09% | – |
| BLUE | New | BLUEBIRD BIO INC | $16,480,000 | – | 105,000 | +100.0% | 4.85% | – |
| ARGX | ARGENX SEsponsored adr | $12,429,000 | +3.0% | 150,000 | 0.0% | 3.66% | +49.9% | |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $11,641,000 | +27.1% | 175,000 | +25.0% | 3.43% | +85.0% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $10,938,000 | – | 242,000 | +100.0% | 3.22% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $10,716,000 | +144.2% | 600,000 | +115.6% | 3.15% | +255.2% |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $9,520,000 | +65.0% | 700,000 | -12.5% | 2.80% | +140.1% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $9,214,000 | +25.0% | 235,000 | +56.7% | 2.71% | +81.9% |
| EXEL | New | EXELIXIS INC | $8,608,000 | – | 400,000 | +100.0% | 2.53% | – |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $8,169,000 | -9.1% | 535,000 | +33.8% | 2.40% | +32.2% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $8,085,000 | -11.0% | 660,000 | -30.5% | 2.38% | +29.5% |
| ADMS | Sell | ADAMAS PHARMACEUTICALS INC | $7,620,000 | -1.9% | 295,000 | -9.2% | 2.24% | +42.8% |
| KDMN | Buy | KADMON HLDGS INC | $7,581,000 | +11.5% | 1,900,000 | +18.8% | 2.23% | +62.1% |
| ECYT | Sell | ENDOCYTE INC | $6,900,000 | -65.5% | 500,000 | -77.3% | 2.03% | -49.8% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $6,871,000 | -56.9% | 350,000 | -58.8% | 2.02% | -37.3% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $6,573,000 | – | 23,500 | +100.0% | 1.93% | – |
| AVRO | New | AVROBIO INC | $6,569,000 | – | 230,000 | +100.0% | 1.93% | – |
| GLYC | Buy | GLYCOMIMETICS INC | $6,452,000 | +59.0% | 400,000 | +60.0% | 1.90% | +131.3% |
| VRAY | VIEWRAY INC | $6,228,000 | +7.6% | 900,000 | 0.0% | 1.83% | +56.5% | |
| OBSV | OBSEVA SA | $6,056,000 | +12.2% | 400,000 | 0.0% | 1.78% | +63.2% | |
| TCDA | New | TRICIDA INC | $5,562,000 | – | 186,019 | +100.0% | 1.64% | – |
| BOLD | New | AUDENTES THERAPEUTICS INC | $4,776,000 | – | 125,000 | +100.0% | 1.41% | – |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $4,608,000 | -72.7% | 360,000 | -64.0% | 1.36% | -60.3% |
| KURA | New | KURA ONCOLOGY INC | $4,186,000 | – | 230,000 | +100.0% | 1.23% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $4,163,000 | – | 1,411,247 | +100.0% | 1.22% | – |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $4,143,000 | -64.3% | 355,000 | -21.1% | 1.22% | -48.1% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $4,070,000 | – | 185,000 | +100.0% | 1.20% | – |
| NEOS | NEOS THERAPEUTICS INC | $3,750,000 | -24.7% | 600,000 | 0.0% | 1.10% | +9.5% | |
| LCI | LANNET INC | $3,400,000 | -15.3% | 250,000 | 0.0% | 1.00% | +23.3% | |
| GNCA | New | GENOCEA BIOSCIENCES INC | $3,016,000 | – | 3,525,000 | +100.0% | 0.89% | – |
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $2,759,000 | -55.5% | 450,000 | -47.1% | 0.81% | -35.2% |
| ANAB | Buy | ANAPTYSBIO INC | $1,115,000 | +19.0% | 15,700 | +74.4% | 0.33% | +72.6% |
| ZFGN | New | ZAFGEN INC | $1,046,000 | – | 102,263 | +100.0% | 0.31% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $947,000 | – | 33,000 | +100.0% | 0.28% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $828,000 | – | 14,000 | +100.0% | 0.24% | – |
| EDGE | New | EDGE THERAPEUTICS INC | $773,000 | – | 750,792 | +100.0% | 0.23% | – |
| MOTS | MOTUS GI HLDGS INC | $719,000 | +60.5% | 100,000 | 0.0% | 0.21% | +133.0% | |
| TGTX | Sell | TG THERAPEUTICS INC | $684,000 | -83.9% | 52,000 | -82.7% | 0.20% | -76.7% |
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $608,000 | – | 29,000 | +100.0% | 0.18% | – |
| XBI | Sell | SPDR SERIES TRUSTput | $525,000 | -98.5% | 5,000 | -43.0% | 0.16% | -97.8% |
| LCI | New | LANNET INCcall | $520,000 | – | 2,000 | +100.0% | 0.15% | – |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO Lcall | $122,000 | -93.7% | 2,000 | -97.3% | 0.04% | -90.8% |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -7,500 | -100.0% | -0.05% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -200,000 | -100.0% | -0.20% | – | |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -76,786 | -100.0% | -0.21% | – |
| CPRX | Exit | CATALYST PHARMACEUTICALS INC | $0 | – | -550,000 | -100.0% | -0.27% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -11,100 | -100.0% | -0.36% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -100,000 | -100.0% | -0.47% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -125,092 | -100.0% | -0.57% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -385,000 | -100.0% | -0.58% | – |
| TSRO | Exit | TESARO INC | $0 | – | -61,900 | -100.0% | -0.72% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -1,750,000 | -100.0% | -0.74% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -75,000 | -100.0% | -0.80% | – |
| FXF | Exit | CURRENCYSHARES SWISS FRANC Tswiss franc sh | $0 | – | -45,800 | -100.0% | -0.91% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -500,000 | -100.0% | -0.94% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -1.12% | – |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -400,000 | -100.0% | -1.14% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -314,367 | -100.0% | -1.42% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -45,000 | -100.0% | -1.53% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -350,000 | -100.0% | -1.62% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -1.84% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -120,000 | -100.0% | -2.23% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -750,000 | -100.0% | -2.28% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -550,000 | -100.0% | -2.87% | – |
| MYL | Exit | MYLAN N V | $0 | – | -350,000 | -100.0% | -2.92% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -135,000 | -100.0% | -3.38% | – |
| INCY | Exit | INCYTE CORPput | $0 | – | -8,333 | -100.0% | -16.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.